Tolebrutinib

ADVERTISEMENT

Identification

Molecular formula
C20H25NO4S
CAS Number
1971926-61-8
IUPAC Name
N-(2,3-dihydro-1,4-benzoxathiin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
Molecular Weight
401.48g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2340g/cm3
Synonyms
Benoxathian
Interesting facts

Interesting Facts about N-(2,3-dihydro-1,4-benzoxathiin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine

N-(2,3-dihydro-1,4-benzoxathiin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine is a fascinating compound that belongs to the class of organic molecules known for their intricate structures and potential biological activities. Here are some intriguing insights:

  • Unique Molecular Structure: This compound features a dihydro-benzoxathiin moiety, which contributes to its distinctive properties. The presence of a sulfur atom in this bicyclic structure adds to its reactivity and interactions with other biological molecules.
  • Potential Biological Activity: Compounds with similar structures have been studied for their pharmacological effects. There is ongoing research into their potential as:
    • Antidepressants
    • Anticancer agents
    • Neuroprotective agents
  • Drug Development: As a part of medicinal chemistry, compounds like this one are often synthesized and modified to enhance their effectiveness. Scientists are keen to explore how variations in the molecular structure can influence biological activity.
  • Multifunctional Groups: The compound contains both amine and ether functional groups, which can play critical roles in binding interactions within biological systems, making it a candidate for tailored drug design.

In conclusion, the chemical properties and potential applications of N-(2,3-dihydro-1,4-benzoxathiin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine make it an exciting subject of study for chemists and researchers. As investigations into its biological roles continue, this compound holds the promise of unlocking new pathways in pharmacology and therapeutic interventions.

ADVERTISEMENT